BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16085547)

  • 1. Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma.
    Catalano L; Andretta C; Pace L; Del Vecchio S; Salvatore B; De Rosa G; Buonanno MT; Paone G; Rotoli B
    Hematology; 2005 Aug; 10(4):335-8. PubMed ID: 16085547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy.
    Catalano L; Pace L; Califano C; Pinto AM; De Renzo A; Di Gennaro F; Del Vecchio S; Fonti R; Salvatore M; Rotoli B
    Haematologica; 1999 Feb; 84(2):119-24. PubMed ID: 10091409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc 99m Sestamibi Scanning in Multiple Myeloma--a New look with SPECT-CT.
    Luthra K; Bhave A; Lele RD
    J Assoc Physicians India; 2014 Sep; 62(9):801-12. PubMed ID: 26259316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
    Mele A; Offidani M; Visani G; Marconi M; Cambioli F; Nonni M; Catarini M; Brianzoni E; Berbellini A; Ascoli G; Brunori M; Agostini V; Corvatta L; Isidori A; Spinelli A; Gradari M; Leoni P
    Br J Haematol; 2007 Mar; 136(5):729-35. PubMed ID: 17233770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy and autologous stem cell transplantation.
    Svaldi M; Tappa C; Gebert U; Bettini D; Fabris P; Franzelin F; Osele L; Mitterer M
    Ann Hematol; 2001 Jul; 80(7):393-7. PubMed ID: 11529464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience.
    Villa G; Balleari E; Carletto M; Grosso M; Clavio M; Piccardo A; Rebella L; Tommasi L; Morbelli S; Peschiera F; Gobbi M; Ghio R
    J Exp Clin Cancer Res; 2005 Sep; 24(3):355-61. PubMed ID: 16270521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
    Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R
    Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different patterns of technetium-99m sestamibi uptake in multiple myeloma.
    Pace L; Catalano L; Pinto A; De Renzo A; Di Gennaro F; Califano C; Del Vecchio S; Rotoli B; Salvatore M
    Eur J Nucl Med; 1998 Jul; 25(7):714-20. PubMed ID: 9662593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
    Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
    Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
    Alper E; Gurel M; Evrensel T; Ozkocaman V; Akbunar T; Demiray M
    Nucl Med Commun; 2003 May; 24(5):537-42. PubMed ID: 12717071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scintigraphy with technetium-99m methoxyisobutylisonitrile in multiple myeloma patients: correlation with the International Staging System.
    Koutsikos J; Grigoraki V; Athanasoulis T; Velidaki A; Mamoulakis C; Zomas A; Anagnostopoulos N; Georgiou E; Dimopoulos MA; Zerva C
    Hell J Nucl Med; 2006; 9(3):177-80. PubMed ID: 17160159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc-99m MIBI scintigraphy in multiple myeloma: prognostic value of different Tc-99m MIBI uptake patterns.
    Bacovsky J; Myslivecek M; Scudla V; Koranda P; Buriankova E; Minarik J; Pika T; Zapletalova J
    Clin Nucl Med; 2010 Sep; 35(9):667-70. PubMed ID: 20706038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
    Giovanella L; Taborelli M; Ceriani L; Zucca E; Cavalli F; Delaloye AB
    Nucl Med Commun; 2008 Jun; 29(6):535-41. PubMed ID: 18458600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
    Myslivecek M; Nekula J; Bacovsky J; Scudla V; Koranda P; Kaminek M
    Nucl Med Rev Cent East Eur; 2008; 11(1):12-6. PubMed ID: 19173182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.
    Pace L; Catalano L; Del Vecchio S; Di Gennaro F; De Renzo A; Sica G; Califano C; Tedesco N; Borrelli G; Rotoli B; Salvatore M
    Eur J Nucl Med; 2001 Mar; 28(3):304-12. PubMed ID: 11315597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate.
    Alexandrakis MG; Kyriakou DS; Passam F; Koukouraki S; Karkavitsas N
    Ann Hematol; 2001 Jun; 80(6):349-53. PubMed ID: 11475149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
    Fallahi B; Beiki D; Mousavi SA; Gholamrezanezhad A; Eftekhari M; Fard-Esfahani A; Alimoghaddam K; Mirpour S; Eskandarian A; Saghari M
    Hell J Nucl Med; 2009; 12(3):255-9. PubMed ID: 19936339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of 99mTc-MIBI whole body scintigraphy in active and in remission multiple myeloma.
    Fallahi B; Saghari M; Fard Esfahani A; Eftekhari M; Iravani M; Beiki D; Dabbagh Kakhki VR; Sadeghi R
    Hell J Nucl Med; 2005; 8(3):165-8. PubMed ID: 16390023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scintigraphy using (99m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myeloma.
    Bacovsky J; Scudla V; Myslivecek M; Nekula J; Vytrasová M
    Neoplasma; 2005; 52(4):302-6. PubMed ID: 16059646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.